Educational Alliance to Optimize CV risk management
CV Risk Master Classes: Applying new insights to clinical practice
These lectures have been recorded during the CardioVascular Risk Master Class Latin American chapter, held on
November 1-2, 2013 in Bogota, Colombia. The presentations are intended for educational support of participants to the meeting. To view and open the presentations an additional log-on with a passcode is required. This passcode is provided to meeting participants only.
Update on new CV risk reduction guidelines: An international perspective
Prof. John Deanfield, MD, University College London, United Kingdom
Macrovascular disease in diabetes: Opportunities for lipid management
Prof. John Betteridge, MD, University College London, United Kingdom
Update on new CV risk reduction guidelines: An international perspective
Dr. Kees Hovingh, MD, Academic Medical Centre, Amsterdam, the Netherlands
The unassailable case for LDL-c lowering & statin therapy
Dr. Kees Hovingh, MD, Academic Medical Centre, Amsterdam, Netherlands
How does BP lowering prevent the clinical manifestations of CVD
Prof. Luis Ruilope, MD, Madrid, Spain
The kidney & statin therapy: Friend or Foe?
Prof. Raul Santos, MD, Sao Paulo Medical School, Sao Paolo, Brazil
The challenge for CV risk management in Latin America
Prof. John Deanfield, MD, UCL, London, United Kingdom
Share this page with your colleagues and friends: